Pharmaceutical Solvent Market Growth Drivers and Challenges:
Growth Drivers
- Expansion and Innovation in Chemical Industry - It was observed that the investment in green technology in 2021 reached USD 750 billion, with a significant increase from 2020. Innovations in the chemical industry such as the growing utilization of green chemical processes for drugs and medicines manufacturing are estimated to increase the sales of pharmaceutical solvents during the forecast period.
- Rise in Exportation of Pharmaceutical Products - It was observed that with a total value of USD 660 billion, pharmaceutical products ranked among the top five global trade products in 2020. The top exporters of pharmaceutical products in 2020 were Switzerland (USD 10%), Germany (USD 14%), Ireland (USD 10%), Belgium (USD 6.5%), and the United States (USD 10%).
- Globally Rising Healthcare Expenditure - As per the data from World Bank global healthcare expenditures are currently estimated at 9.83% of the GDP (2019).
- Growth and Expansion of the Pharmaceutical Industry - For instance, the pharmaceutical industry in India is expected to reach approximately USD 60 billion by 2025, and about USD 100 billion by 2031.
- Rapid Development and Innovation in Generic Drugs - The FDA funded nearly USD 20 million in generic drug science and research programs and issued 149 product-specific guidance (PSGs) about generic drug development.
Challenges
- Stringent Regulations on the Use of Solvents in Developed Countries - Regulation in Europe is putting more pressure on manufacturers to replace specific chemicals. Despite being used in relatively modest amounts, they have a significant negative impact on the environment and human health. Therefore, the use of solvents still contributes significantly to volatile organic compound (VOC) emissions. Solvent emissions make up 35% of VOC emissions in the UK. 36 The European Environmental Agency for the European Economic Area revealed higher values of 42%.
- Highly Volatile Solvents Pose a Transport and Storage Concern
- Limited Use of Toxic and Hazardous Solvents
Pharmaceutical Solvent Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
4.5% |
|
Base Year Market Size (2025) |
USD 5.18 billion |
|
Forecast Year Market Size (2035) |
USD 8.04 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of pharmaceutical solvent is assessed at USD 5.39 billion.
The global pharmaceutical solvent market size was over USD 5.18 billion in 2025 and is anticipated to witness a CAGR of around 4.5%, crossing USD 8.04 billion revenue by 2035.
The North America pharmaceutical solvent market is anticipated to secure a 36% share by 2035, driven by the large number of developed pharmaceutical industries in the region.
Key players in the market include BASF SE, Bayer AG, Clariant International Ltd, Exxon Mobil Corporation., Dow Chemical Company, Brenntag SE, Pon Pure Chemicals Group, Mitsui Chemicals, Inc., LyondellBasell Industries Holdings B.V., PPG Industries, Inc.
